Markus Reindl
Dr. Markus Reindl is currently serving as the University professor in Clinical Department of Neurology, Medical University of Innsbruck, Austria. His main research focus was the pathogenic and diagnostic role of human autoantibodies directed against different central nervous system tissue antigens, mainly the myelin oligodendrocyte glycoprotein (MOG), aquaporin-4 (AQP4) and NMDA-receptor in demyelinating diseases such as multiple sclerosis, acute disseminated encephalomyelitis and neuromyelitis optica. Research activities were also dedicated to the analysis of interactions of cells from the immune and central nervous system and the expression of alpha-synuclein in glial cells and its impact in the pathogenesis of Parkinsonian disorders. Markus Reindl also played a leading role in Austrian investigations on comparative genomics of neurological diseases such as multiple sclerosis or atherosclerosis and stroke, and on the role of risk factors for multiple sclerosis.